Resources

Selected
  • 昊华科技2024年商誉
Type of publications
Regions
Diseases
380 results found
2024 ∙ JCVI
Flu vaccines 2025 to 2026: JCVI advice
Recommendation Europe United Kingdom Influenza
Download:
2024 ∙ JCVI
Shingles (herpes zoster) vaccination programme: JCVI statement, November 2024
Recommendation Europe United Kingdom Herpes zoster
Download:
2024 ∙ Conseil Supérieur de la Santé (CSS)
Vaccination against RSV (adults) – revision 2024
Recommendation Europe Belgium Older adults RSV (Respiratory syncytial virus)
Download:
2024
SoPs of the Chad NITAG
Functioning Africa Chad
Download:
2024 ∙ ATAGI
ATAGI interim statement on the use of vaccines for prevention of mpox in 2024
Recommendation Western Pacific Australia Mpox
Download:
2024 ∙ ATAGI
ATAGI statement on the transition from quadrivalent to trivalent seasonal influenza vaccines in Australia
Recommendation Western Pacific Australia Influenza
Download:
2024
CoPI - List of core members
Functioning Africa Mozambique health policy
Download:
2024 ∙ ACIP
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–25 Influenza Season
Recommendation Americas United States of America Influenza
Download:
2024 ∙ ACIP
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the ACIP — United States, 2024
Recommendation Americas United States of America older adults RSV (Respiratory syncytial virus)
Download:
2024 ∙ ACIP
GRADE of Protein subunit RSV vaccines (GSK Arexvy and Pfizer Abrysvo) in older adults
Background paper Americas United States of America older adults GRADE RSV (Respiratory syncytial virus)
Loading...